Schedule 13D ownership disclosure

TC BioPharm (Holdings) plc

Security class unavailable · CUSIP: 87807D103

Event date: 2021-02-10

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
86,481,822
Percent of class
26.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-22-021888
Form type
SC 13D
Filer
Renaissance Capital Partners Ltd
CIK
CIK 1920179
Filed
Apr 27, 2022
Reporting period
Feb 10, 2021
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub